1. Home
  2. GNLX vs LFMDP Comparison

GNLX vs LFMDP Comparison

Compare GNLX & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.72

Market Cap

123.1M

Sector

Health Care

ML Signal

HOLD

Logo LifeMD Inc.

LFMDP

LifeMD Inc.

N/A

Current Price

$23.15

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNLX
LFMDP
Founded
2001
N/A
Country
United States
United States
Employees
26
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
123.1M
N/A
IPO Year
2022
2012

Fundamental Metrics

Financial Performance
Metric
GNLX
LFMDP
Price
$2.72
$23.15
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$17.25
N/A
AVG Volume (30 Days)
318.4K
1.9K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
9.47
141.67
EPS
N/A
N/A
Revenue
$8,000.00
$12,468,578.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
49.79
52 Week Low
$2.29
$18.50
52 Week High
$8.54
$24.20

Technical Indicators

Market Signals
Indicator
GNLX
LFMDP
Relative Strength Index (RSI) 47.63 40.35
Support Level $2.39 $22.90
Resistance Level $3.02 $23.24
Average True Range (ATR) 0.20 0.12
MACD 0.01 -0.03
Stochastic Oscillator 52.33 0.00

Price Performance

Historical Comparison
GNLX
LFMDP

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

About LFMDP LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

Share on Social Networks: